Burnout and workload among clinical educators in physiotherapy teaching clinics: an observational study.

Cannabis legalization represents one of the most significant natural policy experiments affecting public health in the United States []. While cannabis remains federally illegal in the U.S. as a controlled substance, thirty-one individual states (and Washington, DC) have decriminalized cannabis use, and twenty-four have legalized cannabis for adult use []. At the same time, scientific evidence has associated cannabis use with increased risk of cannabis use disorder, adverse mental health and perinatal outcomes, and cardiovascular disease [, –]. Further evidence suggests that the public health impact of state legalization is not uniform – it is shaped by local control and regulatory decisions that vary significantly across jurisdictions [–]. Understanding how local elected officials prioritize and frame cannabis policy issues is therefore essential for predicting and influencing public health outcomes. Health equity considerations are central to cannabis policy. cannabis retailers may disproportionately concentrate in lower-income and minority communities [], potentially exacerbating existing health disparities. Meanwhile, the legacy of racialized enforcement of cannabis prohibition has produced profound health and socioeconomic harms in communities of color []. Local policy decisions about retail licensing, taxation, and social equity programs may determine whether legalization ameliorates or exacerbates these disparities. Yet we know little about how elected officials who make these decisions prioritize health equity relative to other considerations. The liberalization of cannabis policy has also introduced a complex set of laws and policies aiming to eliminate the illegal market, safeguard and regulate the legal market, and provide access to medicinal and/or adult-use cannabis. Twenty-six states and D.C. offer some form of expungement of criminal records for previous cannabis offenses [, ], and several have established licensing programs for groups disproportionately impacted by the War on Drugs []. In this increasingly favorable policy environment, the legal cannabis industry has grown rapidly, intensifying marketing practices and competition among cannabis businesses []. As a result, these businesses now produce a wide range of product types at increasingly higher potency levels [], collectively generating significant revenue. In 2025, annual sales in the US market are estimated to reach $34 billion [].